Your Article Summary
See Latest ArticlesHBeAg seroconversion as an important end point in the treatment of chronic hepatitis B
Hepatology International, 06/26/09
Liaw YF et al. - Early induction of HBeAg seroconversion with interferon-based therapy or oral nucleos(t)ide analogues has important clinical and socioeconomic implications for the management of CHB.
Related Articles
Entecavir for the long-term treatment of chronic hepatitis B
Expert Review of Anti-infective Therapy, 11/09/09
Relevance Score: 83%
Hepatitis B Virus Resistance to Nucleostide Analogues
Gastroenterology, 10/28/09
Relevance Score: 82%
Impact of Routine Hepatitis B Immunization on the Prevalence of Chronic Hepatitis B Virus Infection in the Marshall Islands and the Federated States of Micronesia
The Pediatric Infectious Disease Journal, 10/27/09
Relevance Score: 82%
Therapeutic vaccination and novel strategies to treat chronic HBV infection
Expert Review of Gastroenterology & Hepatology, 10/16/09
Relevance Score: 82%
Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B
Hepatology, 11/18/09
Relevance Score: 81%
Today in Hepatitis...keeping you current
Receive free subspecialty "5-minute updates" via email
Duration of hepatitis E viremia in pregnancy
International Journal of Gynecology & Obstetrics, 12/02/09
Prevalence of hepatitis E virus in Chinese blood donors
Journal of Clinical Microbiology, 12/02/09
Molecular Characteristics of Occult Hepatitis B Virus from Blood Donors in the southeast China
Journal of Clinical Microbiology, 12/02/09